These learning activities are suitable for, but not limited to, diabetes specialists, primary care physicians, specialist diabetes nurses, cardiologists, and all other healthcare professionals interested in the treatment of type 2 diabetes.
Following participation in these educational activities, you will be able to:
- Discuss the importance of timely treatment of type 2 diabetes and its impact on patient health and outcomes.
- Compare the efficacy and safety profiles of once weekly GLP-1RAs.
- Explain the next generation of GLP-1RAs including the mode of absorption, mechanism of action, dosing schedule, pharmacokinetic/pharmacodynamic properties, glycemic/weight loss efficacy and safety.
An application has been made to the UEMS EACCME® for CME accreditation of this activity.
This program is made possible thanks to an independent educational grant from Novo Nordisk A/S.